Tip: Access positions for across all investors

Analyze quarterly positions in Therapeutics Acquisition Cor with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Therapeutics Acquisition Cor stock

Who bought or sold THERAPEUTICS ACQUISITION COR this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
BlackRock 1.5M $21M 0% Dec 2020
Perceptive Advisors 1.5M $21M 0% Dec 2020
Boxer Capital 1.5M $21M 0% Dec 2020
Franklin Resources 1.0M $14M 0% Dec 2020
venBio Select Advisor 1.0M $14M 0% Dec 2020
Bain Capital Life Sciences Investors 1.0M $14M 0% Dec 2020
BVF 955k $13M -5% Dec 2020
T. Rowe Price Associates 922k $13M 0% Dec 2020
Wellington Management Company 878k $12M -3% Dec 2020
Citadel Advisors 500k $6.3M 0% Dec 2020
Logos Global Management 500k $7.0M 0% Dec 2020

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Therapeutics Acquisition Cor?

Cormorant Asset Management 500k $7.0M 0% Dec 2020
Rtw Investments 490k $6.8M 0% Dec 2020
Foresite Capital Management V 350k $4.9M 100% Dec 2020
Foresite Capital Management IV 350k $4.9M 0% Dec 2020
Henderson Group 124k $1.7M -1% Dec 2020
TD Asset Management 49k $687k 0% Dec 2020
Monashee Investment Management 47k $658k 0% Dec 2020
Silverarc Capital Management 39k $543k 100% Dec 2020
Sphera Funds Management 20k $279k 0% Dec 2020
Sigma Planning 12k $159k 100% Dec 2020
Wells Fargo & Company 2.0k $28k 100% Dec 2020
Wolverine Asset Management 1.0k $14k 100% Dec 2020
UBS Group 948.00 $13k 100% Dec 2020
Advisor Group Holdings 100.00 $1.0k 100% Dec 2020